| Open Price | 356.00 | Shares Traded | 5743 |
| High Price | 360.85 | 52 Wk High | 386.50 |
| Low Price | 356.00 | 52 Wk Low | 265.00 |
| Previous Close | 355.95 | Face Value | 1.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Open Price | 358.00 | Shares Traded | 631127 |
| High Price | 360.80 | 52 Wk High | 386.75 |
| Low Price | 356.85 | 52 Wk Low | 264.75 |
| Previous Close | 357.10 | Face Value | 1.00 |
| 52 Wk High Date | - | 52 Wk Low Date | - |
| Key Financials | Latest Qrtr. | Trailing Yr. | Full Yr. |
| Year End | Mar, 2012 | Mar, 2012 | Mar, 2012 |
| Sales (Rs.cr) | 450.20 | 1546.82 | 1546.82 |
| Net Profit (Rs.cr) | 148.23 | 265.30 | 265.30 |
| Net Profit Var (%) | 125.00 | 25.00 | 25.00 |
| EPS (Rs) | - | 9.80 | |
| P/E Ratio | - | 36.40 | 36.40 |
| Operating Profit Margin | - | 20.10 | - |
| CPS (Rs.) | - | - | 10.60 |
| P/C Ratio | - | - | 33.70 |
| Div% | - | - | 200.00 |
| Related Companies | ||
| Stock Name | Price | |
| CIPLA | 311.45 | |
| JBCHEPHARM | 62.90 | |
| JAYANTVITAMINS | 3.00 | |
| MERIND | 200.00 | |
| PIRHEALTH | 424.50 | |
| RANBAXY | 506.00 | |
| UNICHEMLAB | 131.80 | |
| ALEMBICLTD | 15.20 | |
| LYKALABS | 9.70 | |
| TTKHEALTH | 358.15 | |
| Fundamentals | |
| Market Capital (Rs.cr) | 9656.85 |
| EPS (Rs.)(TTM) | |
| P/E Ratio(TTM) | 36.40 |
| Book Value (Rs.) | 80.80 |
| Price to Book Value | 4.42 |
| Equity (Rs.cr.) | 27.05 |
| Traded Value (Rs.lac) | 301.25 |
| Announcements | |
| 08-02-2011 | Glenmark announces positive results from the multi-centre study of Crofelemer |
| 08-11-2010 | Glenmark confirms patent infringement suit for |
| 19-11-2010 | Glenmark Pharmaceuticals allots equity shares |
| 27-10-2010 | Glenmark Pharmaceuticals allots shares |
| 31-01-2012 | Glenmark Pharmaceuticals appoints additional directors |
| 09-11-2011 | Glenmark Pharmaceuticals appoints director |
| 23-01-2012 | Glenmark Pharmaceuticals gets UK MHRA nod for Rizatriptan Benzonate tablets |
| 10-12-2011 | Glenmark Pharmaceuticals issues stock options |
| 02-04-2011 | Glenmark Pharmaceuticals issues stok options |
| 09-05-2012 | Glenmark Pharmaceuticals recommends dividend |
| 16-07-2011 | Glenmark Pharmaceuticals to announce Q1 results |
| 01-11-2011 | Glenmark Pharmaceuticals to announce Q2 results |
| 24-01-2011 | Glenmark Pharmaceuticals to announce Q3 results |
| Gross Deliverables | |||||
| Date | Del. Shares | Trd. Qty. | Del.(%) | Del. Value | Turnover |
| 15-05-2012 | 42472 | 121854 | 34.85 | 15517145 | 43,779.90 |
| 11-05-2012 | 108028 | 255388 | 42.30 | 37566737 | 89,188.00 |
| 09-05-2012 | 20481 | 70134 | 29.20 | 6958420 | 23,817.10 |
| 08-05-2012 | 9373 | 43262 | 21.67 | 3090747 | 14,399.00 |
| 04-05-2012 | 42290 | 76163 | 55.53 | 14378600 | 25,932.90 |
